We are live on ! Find out more
RANI icon

Rani Therapeutics

15 hedge funds and large institutions have $19.6M invested in Rani Therapeutics in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

5.57% more ownership

Funds ownership: 0%5.57% (+5.6%)

Holders
15
Holders Change
+15
Holders Change %
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NFGH
1
Nan Fung Group Holdings
Hong Kong
$8.8M +$8.54M +493,584 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.05M +$4.9M +283,213 New
CCM
3
CAAS Capital Management
New York
$1.34M +$1.3M +75,000 New
Goldman Sachs
4
Goldman Sachs
New York
$1.08M +$1.05M +60,649 New
Squarepoint
5
Squarepoint
New York
$891K +$865K +50,000 New
Stifel Financial
6
Stifel Financial
Missouri
$676K +$656K +37,950 New
Millennium Management
7
Millennium Management
New York
$517K +$502K +28,996 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$385K +$374K +21,639 New
State Street
9
State Street
Massachusetts
$351K +$341K +19,700 New
Northern Trust
10
Northern Trust
Illinois
$204K +$198K +11,430 New
CH
11
Canton Hathaway
Rhode Island
$178K +$173K +10,000 New
UBS Group
12
UBS Group
Switzerland
$55K +$53.1K +3,070 New
Bank of America
13
Bank of America
North Carolina
$26K +$25.4K +1,467 New
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$18K +$17.3K +1,000 New
Wells Fargo
15
Wells Fargo
California
$1K +$692 +40 New

RANI Hedge Fund Activity: Q3 2021 in Review

15 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Rani Therapeutics (RANI) for Q3 2021, worth a combined $19.6M.

Buyers outnumbered sellers: 15 funds opened new RANI positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Nan Fung Group Holdings, opening a new position worth an estimated $8.54M.

  • 15 institutional investors held Rani Therapeutics (RANI) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $19.6M of Rani Therapeutics stock for Q3 2021.
  • 15 funds opened new Rani Therapeutics positions in Q3 2021 and 0 closed out, a net change of +15 holders.
  • The largest Rani Therapeutics buyer in Q3 2021 was Nan Fung Group Holdings, an estimated $8.54M added.

Based on aggregated 13F filings for Q3 2021.